DE3546518C2 - - Google Patents

Info

Publication number
DE3546518C2
DE3546518C2 DE3546518A DE3546518A DE3546518C2 DE 3546518 C2 DE3546518 C2 DE 3546518C2 DE 3546518 A DE3546518 A DE 3546518A DE 3546518 A DE3546518 A DE 3546518A DE 3546518 C2 DE3546518 C2 DE 3546518C2
Authority
DE
Germany
Prior art keywords
diagnostic agent
immunomodulator
agent according
buffer
indicates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3546518A
Other languages
German (de)
English (en)
Inventor
Udo Dr.Med. 8400 Regensburg De Ehrenfeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE3546701A priority Critical patent/DE3546701C2/de
Priority to DE3546518A priority patent/DE3546518C2/de
Priority claimed from DE3510795A external-priority patent/DE3510795C2/de
Priority claimed from DE3546701A external-priority patent/DE3546701C2/de
Application granted granted Critical
Publication of DE3546518C2 publication Critical patent/DE3546518C2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365—Nocardia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE3546518A 1985-03-25 1985-03-25 Expired - Fee Related DE3546518C2 (enExample)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE3546701A DE3546701C2 (de) 1985-03-25 1985-03-25 Diagnostisches Mittel
DE3546518A DE3546518C2 (enExample) 1985-03-25 1985-03-25

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3510795A DE3510795C2 (de) 1985-03-25 1985-03-25 Verfahren zur Herstellung eines mikrobiellen Extrakts, das bei dem Verfahren erhaltene Produkt und ein es enthaltendes Arzneimittel
DE3546701A DE3546701C2 (de) 1985-03-25 1985-03-25 Diagnostisches Mittel
DE3546518A DE3546518C2 (enExample) 1985-03-25 1985-03-25

Publications (1)

Publication Number Publication Date
DE3546518C2 true DE3546518C2 (enExample) 1993-07-15

Family

ID=27192929

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3546518A Expired - Fee Related DE3546518C2 (enExample) 1985-03-25 1985-03-25

Country Status (1)

Country Link
DE (1) DE3546518C2 (enExample)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3334751A1 (de) * 1983-09-26 1985-04-11 Udo Dr. 8400 Regensburg Ehrenfeld Mittel zur diagnose und therapie von malignen tumoren, ein verfahren zu seiner herstellung und seine verwendung sowie die verwendung beschickter liposomen fuer die diagnose und therapie maligner tumoren
DE3336583A1 (de) * 1983-09-26 1985-04-25 Udo Dr. 8400 Regensburg Ehrenfeld Erzeugnis zur diagnose und therapie von malignen tumoren
DE3402312A1 (de) * 1984-01-24 1985-07-25 Udo Dr. 8400 Regensburg Ehrenfeld Mittel zur diagnose und therapie von malignen tumoren sowie zur therapie von schwaechen der zellingen- und humoralen immunabwehr

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3334751A1 (de) * 1983-09-26 1985-04-11 Udo Dr. 8400 Regensburg Ehrenfeld Mittel zur diagnose und therapie von malignen tumoren, ein verfahren zu seiner herstellung und seine verwendung sowie die verwendung beschickter liposomen fuer die diagnose und therapie maligner tumoren
DE3336583A1 (de) * 1983-09-26 1985-04-25 Udo Dr. 8400 Regensburg Ehrenfeld Erzeugnis zur diagnose und therapie von malignen tumoren
DE3402312A1 (de) * 1984-01-24 1985-07-25 Udo Dr. 8400 Regensburg Ehrenfeld Mittel zur diagnose und therapie von malignen tumoren sowie zur therapie von schwaechen der zellingen- und humoralen immunabwehr

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
EHRENFELD, U.: Krebsgeschehen, 5, 132, 1979 *
HUANG, C.: Biochemistry 15, 2362 (1969) *
OSBORNE, M.P. ei.al.: Int. J. Nucl. Med. Biol., 6, 75(1979) *

Similar Documents

Publication Publication Date Title
EP0142641B1 (de) Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr
Mahmood et al. Paralytic shellfish poisons produced by the freshwater cyanobacterium Aphanizomenon flos-aquae NH-5
DE2517316C2 (de) Clavulansäure und deren Salze und diese Verbindungen enthaltende Arzneimittel
DE69531502T2 (de) Monoamid, diamid, thiol enthaltende metall-chelatierende verbindungen
DE69419919T2 (de) Technetium-99m markierte peptide zur bilderzeugung der entzuendung
DE1803987A1 (de) Neues,physiologisch wirksames Peptidolipid und Verfahren zu seiner Herstellung
EP0606683B1 (de) Neue Mittel zur Diagnose von Gefässerkrankungen
DE3109335C2 (de) Ebelacton A und B, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DE2735411A1 (de) Verfahren zur herstellung von acellulaeren vaccinen und nach diesem verfahren gewonnene vaccine
DE3787887T2 (de) Verfahren zum Züchten von Bordetella-Pertussis, ein Pertussis-Toxoid und ein Pertussis-Impfstoff.
DE60006690T2 (de) Antibiotische caprazamycine und verfahren zu deren herstellung
DE3510795C2 (de) Verfahren zur Herstellung eines mikrobiellen Extrakts, das bei dem Verfahren erhaltene Produkt und ein es enthaltendes Arzneimittel
DE3546518C2 (enExample)
DE1017744B (de) Verfahren zur Gewinnung von wachstumsfoerdernden Stoffen fuer therapeutische Zwecke
Winterbauer et al. The role of penicillin-induced bacterial variants in experimental pyelonephritis
DE69839050T2 (de) Bilderzeugungs verfahren und zusammensetzungen
DE3546701C2 (de) Diagnostisches Mittel
DE69518319T2 (de) Verwendung von oberflächenaktiven substanzen zur stabilisierung von peptiden und proteinen zur radiopharmazeutischen verwendung
DE2028403B2 (de) Pepstatin
CH639133A5 (de) Verfahren zur herstellung einer antitumor wirksamen substanz mit immunostimulierender wirkung.
EP0772633B1 (de) Komplexverbindungen zur diagnose von gefässerkrankungen
DE69001000T2 (de) Radioaktives diagnosemittel.
DE3102137A1 (de) Neue antibiotisch wirksame verbindung, komponente b, mikrobiologisches verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE68908958T2 (de) Peptide.
DE2921829C2 (enExample)

Legal Events

Date Code Title Description
Q172 Divided out of (supplement):

Ref country code: DE

Ref document number: 3510795

8110 Request for examination paragraph 44
AC Divided out of

Ref country code: DE

Ref document number: 3510795

Format of ref document f/p: P

8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3546701

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 3546701

AC Divided out of

Ref country code: DE

Ref document number: 3510795

Format of ref document f/p: P

AH Division in

Ref country code: DE

Ref document number: 3546701

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
AH Division in

Ref country code: DE

Ref document number: 3546701

Format of ref document f/p: P

8339 Ceased/non-payment of the annual fee